Yanagaki Mitsuru, Haruki Koichiro, Taniai Tomohiko, Igarashi Yosuke, Yasuda Jungo, Furukawa Kenei, Onda Shinji, Shirai Yoshihiro, Tsunematsu Masashi, Ikegami Toru
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
J Hepatobiliary Pancreat Sci. 2023 Apr;30(4):453-461. doi: 10.1002/jhbp.1246. Epub 2022 Oct 19.
Frailty, represented by sarcopenia and osteopenia, has been associated with worse survival after hepatectomy in patients with hepatocellular carcinoma. Recently, the concept and term "osteosarcopenia" have been proposed, which has been associated with worse outcome in several malignancies.
This study included 227 patients who underwent elective hepatic resection for hepatocellular carcinoma. Osteopenia was evaluated with computed tomographic measurement of pixel density in the midvertebral core of the 11th thoracic vertebra. The skeletal muscle index (SMI) was evaluated with psoas muscle areas at the third lumbar vertebra. Osteosarcopenia was defined as the concomitant occurrence of osteopenia and low SMI. We retrospectively investigated the relationship between osteosarcopenia and disease-free and overall survival.
Osteosarcopenia was identified in 27 (12%) of the patients. Multivariate analysis showed that osteosarcopenia (P < .001), C-reactive protein-to-albumin ratio ≥0.02 (P = .002), and stage ≥III (P ≤ .001) were independent predictors of disease-free survival, while osteosarcopenia (P < .001), Child-Pugh grade B (P = .002), C-reactive protein-to-albumin ratio ≥0.02 (P = .001), low SMI (P ≤ .001), and stage ≥III (P ≤ .001) were independent predictors of overall survival.
Preoperative osteosarcopenia may be a prognostic factor in patients with hepatocellular carcinoma after hepatic resection. Our results suggests that the preoperative maintenance of skeletal muscle and bone density may potentially improve prognosis.
以肌肉减少症和骨质减少为特征的衰弱与肝细胞癌患者肝切除术后较差的生存率相关。最近,“骨肌减少症”这一概念和术语被提出,它与几种恶性肿瘤的不良预后有关。
本研究纳入了227例行择期肝细胞癌肝切除术的患者。通过计算机断层扫描测量第11胸椎椎体中部核心区域的像素密度来评估骨质减少情况。通过测量第三腰椎水平的腰大肌面积来评估骨骼肌指数(SMI)。骨肌减少症定义为骨质减少和低SMI同时存在。我们回顾性研究了骨肌减少症与无病生存期和总生存期之间的关系。
27例(12%)患者被诊断为骨肌减少症。多因素分析显示,骨肌减少症(P <.001)、C反应蛋白与白蛋白比值≥0.02(P = .002)以及III期及以上(P ≤.001)是无病生存期的独立预测因素,而骨肌减少症(P <.001)、Child-Pugh B级(P = .002)、C反应蛋白与白蛋白比值≥0.02(P = .001)、低SMI(P ≤.001)以及III期及以上(P ≤.001)是总生存期的独立预测因素。
术前骨肌减少症可能是肝细胞癌患者肝切除术后的一个预后因素。我们的结果表明,术前维持骨骼肌和骨密度可能潜在地改善预后。